Leonardo Roever: Post-Stroke Seizures Should Not Be Viewed as a Single Clinical Entity
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
”From Acute Symptomatic Seizures to Post-Stroke Epilepsy: A Narrative Review on Diagnosis and Management
Stroke is a leading cause of acquired epilepsy in adults, particularly among the elderly.
However, post-stroke seizures should not be viewed as a single clinical entity.
Acute symptomatic seizures (ASyS) occur within the first seven days post-stroke and are considered provoked events, whereas late-onset symptomatic seizures carry a higher risk of recurrence and may meet the criteria for the practical definition of post-stroke epilepsy (PSE).
This narrative review provides a clinically focused synthesis of current evidence regarding definitions, epidemiology, pathophysiology, risk factors, predictive scores, risk stratification based on EEG and biomarkers, seizure prevention, and management with antiseizure medications (ASMs).
Current evidence does not support routine primary prophylaxis with ASMs for all stroke patients.
Conversely, documented clinical or electrographic seizures require appropriate treatment, and established PSE often necessitates individualized, long-term therapy.
Predictive tools can assist in guiding surveillance, EEG referral, counseling, and follow-up, but they should not serve as automatic triggers for prophylactic treatment.
The choice of ASM must consider seizure type, age, comorbidities, cognitive and psychiatric vulnerability, drug interactions, and secondary vascular prevention.
Future research should focus on validated biomarkers and preventive strategies capable of modifying post-stroke epileptogenesis.”
Title: From Acute Symptomatic Seizures to Post-Stroke Epilepsy: A Narrative Review of Diagnosis and Management
Authors: Tomásia Frezatti, Leonardo Roever, Octávio Pontes-Neto

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA
-
Nov 20, 2026, 06:44Ann Van De Velde: Emerging Advances in Hemoglobinopathies, Sickle Cell Disease and Rare Anemias
-
Nov 20, 2026, 06:29Markus Müller: ABO Blood Groups and the Rare Bombay Phenotype
-
Nov 20, 2026, 05:57Lance Reed: Specialized Blood Components and Clinical Samples for Research and Diagnostics
-
Nov 20, 2026, 05:41Sundas Anjum: Community Engagement and Blood Donation for Thalassemia Care
-
Nov 20, 2026, 05:24A Celebration of Unity and Dedication in Hemophilia Care – Hemophilia Society Mumbai Chapter
-
Nov 20, 2026, 05:09Farhad Sheikh: Prasugrel vs Ticagrelor in Acute Coronary Syndromes
-
Nov 20, 2026, 05:02Jason Acker: Appointed as the Next Editor-in-Chief of Vox Sanguinis
-
Nov 20, 2026, 04:58Sabri Kemahli: International Society of Hematology Celebrates 80 Years of Hematology with Special Webinar